Dabur India share news, announcements and annual reports
NSE: DABURBSE: 500096Personal ProductsMid Cap
Dabur India Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1994 on BSE, Apr 1999 on NSE
Last close ₹365.60down ₹4.40 (1.19%)BSE ₹366.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹370.00.
30 Oct: open ₹370.00, high ₹370.35, low ₹364.20
52-week range of traded prices to 30 Oct 2026
₹354.30Low, 27 Oct 2026₹534.00High, 5 Jan 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹64,856 Cr130th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 32.89
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.68
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.09
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,07,67363.6% delivered
Dabur India share news and announcements
1,208 announcements, routine notices left out, newest first. Page 22 of 25.
Jun 2010
29 Jun · Board meeting
To, inter alia, consider and approve the Un-audited Financial Results for the Quarter ending June 30, 2010.18 Jun · Meeting
Company has fixed the Book Closure from August 20, 2010 to August 31, 2010 for the purpose of Annual General Meeting and for ascertainment of the shareholders entitled to receive dividend, if approved by the shareholders of the Company at the ensuing Annual General Meeting of the Company to be held on August 31, 2010.18 Jun · Business
Vide its letter dated June 18, 2010 that: "The Order dated April 19, 2010 issued by Hon'ble High Court of Judicature at Delhi (certified true copy issued on 2nd June, 2010) sanctioning the Scheme of Amalgamation of Fem Care Pharma Limited (FEM) with Dabur India Limited (DIL) and their respective shareholders, from the appointed date of amalgamation being April 1, 2009, has become effective today i.e. on 18th June, 2010 upon filing of the said Order with the Registrar of companies, NCT of Delhi & Haryana. It is further informed that pursuant to the Scheme of Amalgamation 'RECORD DATE' of Wednesday, June 30, 2010 has been fixed for shares of FEM for ascertaining the names of shareholders/ Beneficial Owners holding equity shares of FEM who would be entitled for the allotment issue of equity shares of DIL, as per the Register of Members maintained by FEM Depositories, in the Share Exchange Ratio as provided in the Scheme of Amalgamation i.e. 5 (five) fully paid up equity shares of Re.1 each of DIL for every 1 (one) fully paid up equity share of Rs. 10 each of FEM."18 Jun · Dividend
Board of Directors of the Company in its meeting held on June 18, 2010 has declared Final Dividend of Re.1.25 per share having face value of Re.1 each (i.e. 125%) on the equity shares of the company for the financial year 2009-10.18 Jun · Results
Standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 285687 lacs for year ending on 31-MAR-2010 against Rs. 239616 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 43315 lacs for the year ending on 31-MAR-2010 against Rs. 37356 lacs for the year ending on 31-MAR-2009.18 Jun · Results
Consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 339137 lacs for year ending on 31-MAR-2010 against Rs. 280543 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 50323 lacs for the year ending on 31-MAR-2010 against Rs. 39121 lacs for the year ending on 31-MAR-2009.17 Jun · Disclosure
Remuneration cum Compensation Committee in their meeting held on June 17, 2010 granted 34,83,455 fresh Stock Options under Dabur Employees Stock Option Scheme 2000 to the eligible employees of the Company with the following terms & conditions : (1) The above options have vesting period 1 to 4 years. (2) The said options shall be exercisable within a period of 3 years after vesting of the same. (3) The said options carry the right to apply for equivalent number of equity shares of the Company of Re.1/- each for cash at par.4 Jun · Board meeting
Inter alia, consider and approve the audited financial results for the financial year ended March 31, 2010 and recommendation of final dividend, if any, for the financial year ended March 31, 2010.
Apr 2010
28 Apr · Grant of Stock Options
The Remuneration cum Compensation Committee in its meeting held today i.e. 28.04.2010 has granted 1,34,607 fresh Stock Options under Dabur Employees Stock Option Scheme 2000 to the eligible employees of the company with the following terms & conditions:- (1) The above options have vesting period of 1year. (2) The said options shall be exercisable within a period of 3 years after vesting of the same. (3) The said options carry the right to apply for equivalent number of equity shares of the Company of Re. 1/- each at par28 Apr · Business
Press release dated April 28, 2010, titled "Dabur 2009-10 Net Surges 28.7% To Highest-Ever Rs.503.53 Cr". The Company has further submitted to the Exchange a copy of the Investors Communication. The copy of the same alongwith the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 69538 lacs for quarter ending on 31-MAR-2010 against Rs. 61691 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 10127 lacs for the quarter ending on 31-MAR-2010 against Rs. 9171 lacs for the quarter ending on 31-MAR-2009.28 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 84879 lacs for quarter ending on 31-MAR-2010 against Rs. 73165 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 13528 lacs for the quarter ending on 31-MAR-2010 against Rs. 10428 lacs for the quarter ending on 31-MAR-2009.23 Apr · Business
By an Order dated April 19, 2010 the Hon'ble High Court of Judicature at Delhi has sanctioned the Scheme of Amalgamation of Fem Care Pharma Limited with Dabur India Limited and their respective shareholders, from the appointed date of amalgamation being April 01, 2009, subject to sanction of the said scheme in respect of the transferor company from the court of competent jurisdiction.9 Apr · Board meeting
To, inter alia, consider and approve the unaudited financial results for the quarter / financial year ended March 31, 2010.
Mar 2010
12 Mar · Business
Update on Scheme of Amalgamation of Fem Care Pharma Limited with Dabur India Limited and their respective shareholders ("the Scheme") as follows -: By an Order made on February 17, 2010, the Hon'ble High Court of Judicature at Delhi had directed to publish Notice of Petition for next hearing, which has been fixed for April 07, 2010 in newspapers. In accordance therewith Notice of Petition were published on March 11, 2010.The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Mar · Disclosure
Disclosure under Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992, the Company has received disclosure from Directors/ Officers informing the details of transactions done by them in the equity shares of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
17 Feb · Business
Equity shareholders and unsecured creditors of the Company at its court convened meetings held on February 01, 2010, unanimously approved the Scheme of Amalgamation of Fem Care Pharma Ltd. ("the Transferor Company") with Dabur India Ltd. ("the Transferee Company") and their respective shareholders. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
29 Jan · Business
Press release dated January 27, 2010, titled "Dabur India Q3 Net Profit Surges 28.3% To Rs 137.84 Crores". The Company has further submitted to the Exchange a copy of the Investor Communication : Quarter ended December 31, 2009. The copy of the same alongwith the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jan · Grant of Stock Options
The Remuneration cum Compensation Committee in its meeting held today i.e. 27.01.2010 has granted 26,345 fresh Stock Options under Dabur Employees Stock Option Scheme 2000 to the eligible employees of the company/ its subsidiary with the following terms & conditions:- (1) The above options have vesting period of 1 to 5 years. (2) The said options shall be exercisable within a period of 3 years after vesting of the same. (3) The said options carry the right to apply for equivalent number of equity shares of the Company of Re. 1/- each at par. Further, the Committee has also cancelled 44,733 stock options issued to employees earlier27 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 92618 lacs for quarter ending on 31-DEC-2009 against Rs. 77865 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 13777 lacs for the quarter ending on 31-DEC-2009 against Rs. 10845 lacs for the quarter ending on 31-DEC-2008.27 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 76430 lacs for quarter ending on 31-DEC-2009 against Rs. 67360 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 11307 lacs for the quarter ending on 31-DEC-2009 against Rs. 10472 lacs for the quarter ending on 31-DEC-2008.7 Jan · Notice of Meeting
By an Order made on December 22, 2009 in Dabur India Limited's Application, the Hon'ble High Court has directed that a meeting of the Equity Shareholders and Unsecured Creditors of the Applicant Company be convened and held on February 01, 2010 for the purpose of considering and if thought fit, approving with or without modification(s), the Amalgamation embodied in the Scheme of Amalgamation of Fem Care Pharma Limited with Dabur India Limited and their respective Shareholders. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
29 Dec · Board meeting
To, inter alia, consider and approve the unaudited financial results for the quarter / nine months ending December 31, 2009.24 Dec · Updates
By an order made on the December 22, 2009, the Hon'ble High Court of Judicature at Delhi has directed that a meeting of the Equity Shareholders and Unsecured Creditors of Dabur India Limited, the Applicant Company, shall be held on February 1, 2010, for the purpose of considering and, if thought fit, approving with or without modification(s), the proposed agreement embodied in the Scheme of Amalgamation of Fem Care Pharma Ltd.("the Transferor Company") wit Dabur India Ltd. ("The Transferee Company ") and their Respective Shareholders.
Oct 2009
26 Oct · Updates
An Investor Communication - Half Year ended September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Oct · Business
Board of Directors of Dabur India Limited ("DIL" or "Transferee Company") at their meeting held on October 26, 2009 have considered and approved the Scheme for Amalgamation of Fem Care Pharma Limited ("FCPL or Transferor Company") with DIL as per terms and conditions mentioned in the Scheme of Amalgamation ("the Scheme") under the provisions of Sections 391 to 394 of the Companies Act, 1956. The salient Features of the Scheme are as under : 1) The Appointed Date for merger under the Scheme is April 1, 2009. 2) In consideration of the Amalgamation of FCPL with DIL, the Company shall allot 5 (five) Equity Share(s) of the face value of Re. 1 each credited as fully paid-up, for every 1 (one) Equity Share of the face value of Rs. 10 each held by the shareholders of FCPL. 3) As a result of the merger, the portion of share capital of FCPL held by DIL (i.e., 32,52,476 equity shares) shall stand cancelled and there would be no issuance of shares by the DIL in relation to such shares . 4) The Scheme is subject to requisite consent/ approval of the shareholders, lenders, creditors of the Company, and sanction of the Hon'ble High Court of Judicature at Delhi and Hon'ble High Court of Judicature at Bombay and the permission or approval of any other statutory or regulatory authorities, which by law may be necessary for the implementation of the Scheme.26 Oct · Grant of Stock Options
The Remuneration cum Compensation Committee in its meeting held today i.e. 26.10.2009 has granted 4937 fresh Stock Options under Dabur Employees Stock Option Scheme 2000 to the eligible employees of the company/ its subsidiary with the following terms & conditions:- (1) The above options have vesting period of 1 to 5 years. (2) The said options shall be exercisable within a period of 3 years after vesting of the same. (3) The said options carry the right to apply for equivalent number of equity shares of the Company of Re. 1/- each at par. Further, the Committee has also cancelled 35,438 stock options issued to employees earlier26 Oct · Business
Press release dated October 26, 2009, titled "Dabur India Q2 Net Profit Surges 30.7% to Rs.140.34 Crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Oct · Dividend
Board of Directors of the Company in its meeting held on October 26, 2009 has declared Interim Dividend of 75% (i.e. Re.0.75 per share having face value of Re.1 each) on the equity shares of the company for the financial year 2009-10.26 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 67221 lacs for quarter ending on 30-SEP-2009 against Rs. 58148 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 11909 lacs for the quarter ending on 30-SEP-2009 against Rs. 10696 lacs for the quarter ending on 30-SEP-2008.26 Oct · Results
Standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 128181 lacs for half year ending on 30-SEP-2009 against Rs. 110565 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 19991 lacs for the half year ending on 30-SEP-2009 against Rs. 17711 lacs for the half year ending on 30-SEP-2008.26 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 84803 lacs for quarter ending on 30-SEP-2009 against Rs. 69116 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 13914 lacs for the quarter ending on 30-SEP-2009 against Rs. 10782 lacs for the quarter ending on 30-SEP-2008.26 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 159069 lacs for half year ending on 30-SEP-2009 against Rs. 129513 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 23053 lacs for the half year ending on 30-SEP-2009 against Rs. 17846 lacs for the half year ending on 30-SEP-2008.
Sep 2009
29 Sep · Board meeting
To inter alia, consider and approve the audited financial results for the quarter / Half year ending September 30, 2009.7 Sep · Management
Dr. Ajay Dua has been appointed as an Additional Director of the company under the category of Independent, Non Executive Director w.e.f. 03.09.2009
Jul 2009
27 Jul · Business
Press release dated July 27, 2009, titled "Dabur India Q1 Net Profit Soars 29.4% to Rs.91.39 Cr". The Company has further submitted to the Exchange a copy of the Investor Communication : Quarter ended June 30, 2009. The copy of the same alongwith the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jul · Grant of Stock Options
Remuneration cum Compensation Committee in its meeting held on July 27, 2009 has granted 1,78,416 fresh Stock Options under Dabur Employees Stock Option Scheme 2000 to the eligible employees of the company with the following terms & conditions:- (1) The above options have vesting period of 1 to 5 years. (2) The said options shall be exercisable within a period of 3 years after vesting of the same. (3) The said options carry the right to apply for equivalent number of equity shares of the Company of Re. 1/- each at par. Further, the committee has also cancelled 34,157 stock options issued to employees earlier.27 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 60961 lacs for quarter ending on 30-JUN-2009 against Rs. 52417 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 8083 lacs for the quarter ending on 30-JUN-2009 against Rs. 7014 lacs for the quarter ending on 30-JUN-2008.27 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 74266 lacs for quarter ending on 30-JUN-2009 against Rs. 60398 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 9139 lacs for the quarter ending on 30-JUN-2009 against Rs. 7065 lacs for the quarter ending on 30-JUN-2008.16 Jul · Meeting
Outcome of Annual General Meeting held on July 15, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jul · Updates
Consequent to the acquisition of 92.15% shareholding in Fem Care Pharma Limited (FEM), Jaquline Inc. USA, a wholly owned subsidiary company of FEM, has become a step down subsidiary company of Dabur India Limited
Jun 2009
29 Jun · Board meeting
Meeting on 27 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”26 Jun · Disclosure
Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 pursuant to acquisition of Shares of Fem Care Pharma Limited by Dabur India Limited. The Shares have been acquired from Promoter Group pursuant to Share Purchase Agreement. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jun · Disclosure
Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 pursuant to acquisition of Shares of Fem Care Pharma Limited by Dabur India Limited. The Shares have been acquired pursuant to the open offer. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
4 May · Business
Press release dated April 29, 2009, titled "Dabur India Q4 Net Profit Surges 31% To Rs 104.3 Cr". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
29 Apr · Grant of Stock Options
Remuneration cum Compensation Committee in its meeting held on April 29, 2009 has granted 2,04,144 fresh Stock Options under Dabur Employees Stock Option Scheme 2000 to the eligible employees of the company with the following terms & conditions:- (1) The above options have vesting period of 1 year. (2) The said options shall be exercisable within a period of 3 years after vesting of the same. (3) The said options carry the right to apply for equivalent number of equity shares of the Company of Re. 1/- each at par. Further, the committee has also cancelled 39,375 stock options issued to employees earlier.29 Apr · Meeting
Company has fixed book closure from July 01, 2009 to July 15, 2009 for the purpose of Annual General Meeting and for ascertainment of the shareholders entitled to receive dividend, if approved by the shareholders of the company at the ensuing Annual General Meeting of the company to be held on July 15, 2009. Further, in case dividend is approved by the shareholders in the aforesaid Annual General Meeting, the Company will make the payment of said Dividend from July 20, 2009 onwards.29 Apr · Updates
Statement of Appropriations (as per Clause 20 of the Listing Agreement). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 73165 lacs for quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 10430 lacs for the quarter ending on 31-MAR-2009.